Osteoarthritis, Knee Clinical Trial
— POKR-pOfficial title:
Prediction of Outcomes Following Total Knee Replacement- Pilot
Verified date | February 2023 |
Source | Brigham and Women's Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study seeks to examine multiple risk factors as predictors of pain and function following total knee arthroplasty (TKA). Risk factors will be measured pre-surgically using psychophysical testing procedures, multimodal evaluation of sleep, standardized questionnaires. Additionally, this study will collect pilot data on a brief mindfulness-based cognitive-behavioral treatment that may help to improve long-term TKA outcomes. The pilot study compared TKA patients that received brief mindfulness-based cognitive behavioral therapy (MBCBT) to the treatment-as-usual (TAU) group from the parent study.
Status | Active, not recruiting |
Enrollment | 40 |
Est. completion date | December 2023 |
Est. primary completion date | April 30, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 45 Years to 100 Years |
Eligibility | Inclusion Criteria: 1. Age 45 or older, 2. Meet the American College of Rheumatology criteria for knee OA, 3. Scheduled to undergo total knee arthroplasty, 4. Facility with the English language that is adequate to complete study procedures Exclusion Criteria: 1. Cognitive impairment preventing completion of study assessment procedures. 2. Myocardial infarction within the past 12 months. 3. Presence of Severe Raynaud's or severe neuropathy, 4. Active vasculitis or severe peripheral vascular disease, 5. Current infection, 6. Use of oral steroids, 7. Recent history of substance abuse or dependence, 8. Known anemia |
Country | Name | City | State |
---|---|---|---|
United States | Brigham and Women's Hospital Pain Management Center | Chestnut Hill | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Brigham and Women's Hospital |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Brief Pain Inventory (BPI) | Measure of pain severity and pain interference | baseline | |
Primary | Brief Pain Inventory (BPI) | Measure of pain severity and pain interference | 6-week | |
Primary | Brief Pain Inventory (BPI) | Measure of pain severity and pain interference | 3-months | |
Primary | Brief Pain Inventory (BPI) | Measure of pain severity and pain interference | 6-months | |
Secondary | Quantitative Sensory Testing (QST) | Measures of responses to standardized stimuli | baseline | |
Secondary | Quantitative Sensory Testing (QST) | Measures of responses to standardized stimuli | 3-months | |
Secondary | Pain Catastrophizing Scale | Assess catastrophic thinking related to pain | baseline | |
Secondary | Pain Catastrophizing Scale | Assess catastrophic thinking related to pain | 6-week | |
Secondary | Pain Catastrophizing Scale | Assess catastrophic thinking related to pain | 3-months | |
Secondary | Pain Catastrophizing Scale | Assess catastrophic thinking related to pain | 6-months | |
Secondary | PROMIS-SF | Measures anxiety and depression symptoms | baseline | |
Secondary | PROMIS-SF | Measures anxiety and depression symptoms | 6-week | |
Secondary | PROMIS-SF | Measures anxiety and depression symptoms | 3-months | |
Secondary | PROMIS-SF | Measures anxiety and depression symptoms | 6-months | |
Secondary | The Western Ontario McMaster Universities Osteoarthritis Scale (WOMAC) | 24 items and is a well-validated, widely-used outcomes measure that yields three indices specific to osteoarthritis: 1) pain, 2) disability and 3) joint stiffness, which are sensitive to treatment, with internal consistency coefficients for all scales above 0.8. | baseline | |
Secondary | The Western Ontario McMaster Universities Osteoarthritis Scale (WOMAC) | 24 items and is a well-validated, widely-used outcomes measure that yields three indices specific to osteoarthritis: 1) pain, 2) disability and 3) joint stiffness, which are sensitive to treatment, with internal consistency coefficients for all scales above 0.8. | 6-week | |
Secondary | The Western Ontario McMaster Universities Osteoarthritis Scale (WOMAC) | 24 items and is a well-validated, widely-used outcomes measure that yields three indices specific to osteoarthritis: 1) pain, 2) disability and 3) joint stiffness, which are sensitive to treatment, with internal consistency coefficients for all scales above 0.8. | 3-months | |
Secondary | The Western Ontario McMaster Universities Osteoarthritis Scale (WOMAC) | 24 items and is a well-validated, widely-used outcomes measure that yields three indices specific to osteoarthritis: 1) pain, 2) disability and 3) joint stiffness, which are sensitive to treatment, with internal consistency coefficients for all scales above 0.8. | 6-months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03895489 -
Effectiveness of the Journey Total Knee Arthroplasty Versus Two Standard of Care Total Knee Arthroplasty Prostheses
|
N/A | |
Completed |
NCT03660943 -
A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain
|
Phase 3 | |
Completed |
NCT04531969 -
Comparison of Outpatient and Inpatient Spa Therapy
|
N/A | |
Completed |
NCT02848027 -
Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx®SD Treatment
|
Phase 3 | |
Completed |
NCT05160246 -
The Instant Effect of Kinesiology Taping in Patients With Knee OA
|
N/A | |
Recruiting |
NCT06080763 -
Biomechanics and Clinical Outcomes in Responders and Non-Responders
|
||
Completed |
NCT03643588 -
The Comparison of HYAJOINT Plus and Hyalgan Hyaluronan Supplement for Knee Osteoarthritis Pain
|
N/A | |
Active, not recruiting |
NCT05100225 -
Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis
|
Phase 2 | |
Active, not recruiting |
NCT04061733 -
New Hydroxyethyl Cellulose Hydrogel for the Treatment of the Pain of Knee Arthrosis
|
N/A | |
Completed |
NCT04051489 -
A Novel Smartphone Application for "Smart" Knee Osteoarthritis Trials
|
||
Recruiting |
NCT05546541 -
Epidemiology and Nutrition
|
||
Recruiting |
NCT05447767 -
Prediction AlgoriThm for regeneraTive Medicine Approach in knEe OA: New Decision-making Process Based on Patient pRofiliNg
|
Phase 2 | |
Not yet recruiting |
NCT04448106 -
Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis
|
Phase 2 | |
Not yet recruiting |
NCT03225911 -
Effect of a Lateral Wedge Insole and Simple Knee Sleeve in Individuals With Knee Osteoarthritis
|
N/A | |
Completed |
NCT05070871 -
A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women
|
N/A | |
Completed |
NCT05703087 -
Positive Cueing in Knee Arthroplasty.
|
N/A | |
Not yet recruiting |
NCT06042426 -
Effects of Perioperative Intravenous Dexamethasone in Clinical Outcomes After Total Knee Arthroplasty in a Hispanic Population
|
Phase 4 | |
Terminated |
NCT02615522 -
Prospective Post Market Clinical Follow-Up of the Primary Knee Endoprosthesis BPK-S Integration
|
||
Not yet recruiting |
NCT02865174 -
Topical Tranexamic Acid and Floseal® in Total Knee Arthroplasty
|
Phase 4 | |
Not yet recruiting |
NCT02854176 -
Somatosensory Stimulation in Knee Osteoarthritis
|
Phase 2 |